Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Protein Kinase Inhibitors"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Shi%2C+Yuankai%22&type=Person&filter%5B%5D=topic_facet%3A%22Protein+Kinase+Inhibitors%22
/vufind/Search/Results?lookfor=%22Shi%2C+Yuankai%22&type=Person&filter%5B%5D=topic_facet%3A%22Protein+Kinase+Inhibitors%22
Search /vufind/Search2/Results?lookfor=%22Shi%2C+Yuankai%22&type=Person&filter%5B%5D=topic_facet%3A%22Protein+Kinase+Inhibitors%22
PubPharm (46)
1
Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation : A pooled analysis of two clinical studies
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2023
von
Yang, S.
|
Wu, S.
|
Zhao, Y.
| +54
Wird geladen...
2
Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer : a pooled analysis from two phase 2 studies
enthalten in:
BMC medicine
| 2023
von
Hu, X.
|
Zhang, S.
|
Ma, Z.
| +27
Wird geladen...
3
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer : a phase Ib study
enthalten in:
BMC cancer
| 2023
von
Hu, X.
|
Cui, X.
|
Wang, Z.
| +16
Wird geladen...
4
Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients : a single-arm, multicenter phase II study (INTELLECT)
enthalten in:
BMC medicine
| 2023
von
Shi, Y.
|
Chen, J.
|
Zhang, H.
| +30
Wird geladen...
5
Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic/recurrent NSCLC patients with EGFR mutation from a phase I/IIa study
enthalten in:
BMC medicine
| 2023
von
Shi, Y.
|
Zhou, J.
|
Zhao, Y.
| +13
Wird geladen...
6
Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer : a multicenter, open-label, first-in-human phase 1 study
enthalten in:
BMC medicine
| 2022
von
Xing, P.
|
Zhao, Q.
|
Zhang, L.
| +5
Wird geladen...
7
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG) : a multicentre, double-blind, randomised phase 3 study
enthalten in:
The Lancet. Respiratory medicine
| 2022
von
Shi, Y.
|
Chen, G.
|
Wang, X.
| +20
Wird geladen...
8
Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC : A Phase 2b Study
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2022
von
Shi, Y.
|
Wu, S.
|
Wang, K.
| +46
Wird geladen...
9
Central Nervous System Efficacy of Furmonertinib (AST2818) Versus Gefitinib as First-Line Treatment for EGFR-Mutated NSCLC : Results From the FURLONG Study
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2022
von
Shi, Y.
|
Chen, G.
|
Wang, X.
| +19
Wird geladen...
10
Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC : A Multicenter, Single-Arm, Phase 2b Study
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2022
von
Shi, Y.
|
Li, B.
|
Wu, L.
| +38
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Protein Kinase Inhibitors
Medienart
46
Aufsätze
45
E-Artikel
45
E-Ressourcen
1
Gedruckte Aufsätze
Zeitschriftentitel
6
Journal of thoracic oncology : official publica...
4
BMC medicine
4
Zhongguo fei ai za zhi = Chinese journal of lun...
3
Journal of hematology & oncology
3
Lung cancer (Amsterdam, Netherlands)
3
The Lancet. Respiratory medicine
3
Thoracic cancer
1
Asia-Pacific journal of clinical oncology
1
BMC cancer
1
Bioanalysis
1
British journal of cancer
1
Cancer communications (London, England)
1
Clinica chimica acta; international journal of ...
1
Current cancer drug targets
1
Endocrine-related cancer
1
Future oncology (London, England)
1
Investigational new drugs
1
Japanese journal of clinical oncology
1
Journal of cancer research and clinical oncology
1
Journal of translational medicine
Alle anzeigen ...
weniger ...
Thema
Protein Kinase Inhibitors
45
Journal Article
36
Research Support, Non-U.S. Gov't
35
EC 2.7.10.1
26
ErbB Receptors
21
Antineoplastic Agents
18
EGFR protein, human
12
Multicenter Study
9
Clinical Trial, Phase I
9
Clinical Trial, Phase II
9
NSCLC
8
53AH36668S
8
Crizotinib
8
Gefitinib
8
Quinazolines
8
Randomized Controlled Trial
8
S65743JHBS
7
Anaplastic Lymphoma Kinase
7
Indoles
6
EGFR T790M mutation
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
26
2020-
20
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
41
Englisch
5
Chinesisch
Haven't found what you're looking for?
Wird geladen...